obstructive sleep apnea

Dec 26, 2023

ImPact Biotech’s IND Application for Padeliporfin VTP; Orphan Drug Designation to Ocelot Bio’s OCE-205 for Ascites; Amylyx’s Phase 3 ORION Study of AMX0035 for PSP; SELLAS Receives FDA Orphan Drug Designation for SLS009 for PTCL Treatment; Apnimed Updated on Second Phase 3 Clinical Study of AD109 for OSA

Sep 20, 2023

Sleep Aids Market: Examining Cutting-Edge Technologies and Major Breakthroughs

Aug 16, 2023

Exploring the World of Anti-snoring Devices: A Comprehensive Market Assessment

May 30, 2023

ATS 2023 Updates: AD109’s Potential as the First Oral Medication for Obstructive Sleep Apnea (OSA)

Jan 12, 2023

Vivos Therapeutics ‘s DNA Oral Appliance for the Treatment of OSA; Arthrex’s TightRope Implant for Pediatric ACL Surgery; Chindex Medical Acquired 10 ViewRay MRIdian Systems; Zimmer Biomet to Acquire Embody; GE HealthCare to buy IMACTIS; Glaukos Announced the iDose TR Exchange Trial

May 30, 2022

Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario

Mar 03, 2022

Noninvasix’s LIVOx™ Central Venous Oxygenation Monitor; LivaNova’s aura6000 System; Oxford BioDynamics’s EpiSwitch® CiRT; Masimo’s SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor; Medtronic’s NuVent™ Eustachian Tube Dilation Balloon; Conformis’s published data for Bilateral Knee Implant Study

Mar 18, 2019

Narcolepsy now a confirmed Autoimmune Disorder

Newsletter/Whitepaper